Cutaneous lymphoscintigraphy in malignant melanoma

Area of Science:

• Nuclear Medicine
• Surgical Oncology
• Dermatology

Background:

• Melanoma commonly metastasizes to regional lymph nodes, necessitating accurate identification of at-risk nodes for effective treatment.
• Traditional lymphadenectomy can be challenging for certain melanoma sites due to unpredictable lymphatic drainage patterns deviating from classical anatomy.
• Accurate staging of melanoma metastasis is crucial for guiding therapeutic decisions, including surgical intervention and lymph node dissection.

Purpose of the Study:

• To evaluate the efficacy of four different radiocolloid agents in determining lymphatic drainage from melanomas.
• To assess the correlation between radiocolloid imaging findings and surgical outcomes in melanoma patients.
• To identify the optimal radiopharmaceutical for mapping lymph node involvement in melanoma.

Main Methods:

• A review of recent reports from four institutions utilizing four radiocolloids: colloidal 198gold, 99mtechnetium antimony sulfur colloid (99mTcSbSC), 99mtechnetium sulfur colloid (99mTcSC), and micro 99mtechnetium sulfur colloid (micro 99mTcSC).
• Assessment of lymph node drainage patterns using scintigraphy following radiocolloid administration.
• Correlation of imaging results with surgical findings to determine the accuracy of lymph shed mapping.

Main Results:

• All four radiocolloid agents demonstrated good scanning capabilities for mapping lymphatic drainage from melanomas.
• Excellent correlation was observed between radiocolloid imaging findings and subsequent surgical findings.
• Frequent observation of lymphatic drainage to second and third nodal groups, some of which were not clinically predictable, highlighting the value of imaging.

Conclusions:

• Radiocolloid imaging is a valuable tool for accurately determining lymphatic drainage pathways in melanoma patients, even in cases with unpredictable nodal involvement.
• 99mtechnetium sulfur colloid (99mTcSC) and micro 99mtechnetium sulfur colloid (micro 99mTcSC) are identified as the preferred radiopharmaceuticals due to their performance.
• The use of these agents can improve the precision of regional lymphadenectomy, potentially leading to better patient outcomes in melanoma management.